Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells

Myasthenia Gravis (MG) is a neurological autoimmune disease characterized by disabling muscle weaknesses due to anti-acetylcholine receptor (AChR) autoantibodies. To gain insight into immune dysregulation underlying early-onset AChR+ MG, we performed an in-depth analysis of peripheral mononuclear blood cells (PBMCs) using mass cytometry. PBMCs from 24 AChR+ MG patients without thymoma and 16 controls were stained with a panel of 37 antibodies. Using both unsupervised and supervised approaches, we observed a decrease in monocytes, for all subpopulations: classical, intermediate, and non-classical monocytes. In contrast, an increase in innate lymphoid cells 2 (ILC2s) and CD27- γδ T cells was observed. We further investigated the dysregulations affecting monocytes and γδ T cells in MG. We analyzed CD27- γδ T cells in PBMCs and thymic cells from AChR+ MG patients. We detected the increase in CD27- γδ T cells in thymic cells of MG patients suggesting that the inflammatory thymic environment might affect γδ T cell differentiation. To better understand changes that might affect monocytes, we analyzed RNA sequencing data from CD14+ PBMCs and showed a global decrease activity of monocytes in MG patients. Next, by flow cytometry, we especially confirmed the decrease affecting non-classical monocytes. In MG, as for other B-cell mediated autoimmune diseases, dysregulations are well known for adaptive immune cells, such as B and T cells. Here, using single-cell mass cytometry, we unraveled unexpected dysregulations for innate immune cells. If these cells are known to be crucial for host defense, our results demonstrated that they could also be involved in autoimmunity.

[1]  S. Demeret,et al.  Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus , 2022, Annals of neurology.

[2]  Bin Wang,et al.  Abnormal Changes of Monocyte Subsets in Patients With Sjögren’s Syndrome , 2022, Frontiers in Immunology.

[3]  F. Ginhoux,et al.  Twin study reveals non-heritable immune perturbations in multiple sclerosis , 2022, Nature.

[4]  M. Karampetsou,et al.  Innate Lymphoid Cells in Autoimmune Diseases , 2022, Frontiers in Immunology.

[5]  E. Segura,et al.  TLR or NOD receptor signaling skews monocyte fate decision via distinct mechanisms driven by mTOR and miR-155 , 2021, Proceedings of the National Academy of Sciences.

[6]  B. Xiao,et al.  Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis , 2021, Cell discovery.

[7]  A. Behren,et al.  Targeting butyrophilins for cancer immunotherapy. , 2021, Trends in immunology.

[8]  B. Becher,et al.  Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature , 2021, Acta Neuropathologica.

[9]  J. Levitt,et al.  CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential , 2021, Frontiers in Immunology.

[10]  F. Detterbeck,et al.  Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis , 2020, Proceedings of the National Academy of Sciences.

[11]  Shaochong Zhang,et al.  Genetic landscape and autoimmunity of monocytes in developing Vogt–Koyanagi–Harada disease , 2020, Proceedings of the National Academy of Sciences.

[12]  Y. Parman,et al.  CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS , 2020, Frontiers in Immunology.

[13]  E. Fadel,et al.  Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects , 2020, Frontiers in Immunology.

[14]  A. Amirzargar,et al.  IL-27 and autoimmune rheumatologic diseases: The good, the bad, and the ugly. , 2020, International immunopharmacology.

[15]  S. Koo,et al.  Changes of frequency and expression level of CD161 in CD8+ T cells and natural killer T cells in peripheral blood of patients with systemic lupus erythematosus , 2020, Microbiology and immunology.

[16]  P. Carlsson,et al.  Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets , 2020, Frontiers in Immunology.

[17]  M. Ciofani,et al.  Regulation of γδ T Cell Effector Diversification in the Thymus , 2020, Frontiers in Immunology.

[18]  N. McGovern,et al.  The human fetal thymus generates invariant effector γδ T cells , 2019, The Journal of experimental medicine.

[19]  Jie Zhu,et al.  Effects of Follicular Helper T cells and Inflammatory Cytokines on Myasthenia Gravis. , 2019, Current molecular medicine.

[20]  F. Ginhoux,et al.  Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. , 2019, Immunity.

[21]  anonymous,et al.  Comprehensive review , 2019 .

[22]  V. Martinelli,et al.  Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis , 2019, Front. Immunol..

[23]  L. Quintana-Murci,et al.  A Call for Blood-In Human Immunology. , 2019, Immunity.

[24]  Wen-Tao Ma,et al.  The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review , 2019, Front. Immunol..

[25]  C. Hedrick,et al.  Nonclassical Monocytes in Health and Disease. , 2019, Annual review of immunology.

[26]  Chuan Wang,et al.  Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE , 2019, Cellular & Molecular Immunology.

[27]  Nadine Dragin,et al.  Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis. , 2019, Journal of autoimmunity.

[28]  Huy Q. Dinh,et al.  Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[29]  F. Bolgert,et al.  Regulatory B cells in myasthenia gravis are differentially affected by therapies , 2018, Annals of clinical and translational neurology.

[30]  Weihui Zhang,et al.  Modular bioinformatics analysis demonstrates that a Toll-like receptor signaling pathway is involved in the regulation of macrophage polarization , 2018, Molecular medicine reports.

[31]  F. Calzetti,et al.  Human dendritic cell subset 4 (DC4) correlates to a subset of CD14dim/-CD16++ monocytes. , 2018, The Journal of allergy and clinical immunology.

[32]  I. Prinz,et al.  Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases. , 2017, Journal of autoimmunity.

[33]  L. Servais,et al.  Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins. , 2017, Journal of autoimmunity.

[34]  P. Loke,et al.  By CyTOF: Heterogeneity of Human Monocytes. , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[35]  Min Zhang,et al.  High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients , 2017, Neurological Sciences.

[36]  N. Hacohen,et al.  Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors , 2017, Science.

[37]  C. Hedrick,et al.  Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[38]  M. Rojas,et al.  Infiltrating CD16+ Are Associated with a Reduction in Peripheral CD14+CD16++ Monocytes and Severe Forms of Lupus Nephritis , 2016, Autoimmune diseases.

[39]  F. Shi,et al.  Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia Gravis , 2016, The Journal of Immunology.

[40]  A. Marx,et al.  Randomized Trial of Thymectomy in Myasthenia Gravis. , 2016, The New England journal of medicine.

[41]  L. Öhman,et al.  Altered expression of Butyrophilin (BTN) and BTN‐like (BTNL) genes in intestinal inflammation and colon cancer , 2016, Immunity, inflammation and disease.

[42]  O. Hubscher,et al.  Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis , 2014, Clinical and experimental immunology.

[43]  S. Berrih-Aknin,et al.  Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. , 2014, Journal of autoimmunity.

[44]  A. E. Sousa,et al.  Human γδ Thymocytes Are Functionally Immature and Differentiate into Cytotoxic Type 1 Effector T Cells upon IL-2/IL-15 Signaling , 2014, The Journal of Immunology.

[45]  Sean C. Bendall,et al.  Normalization of mass cytometry data with bead standards , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[46]  E. Fadel,et al.  SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients. , 2013, Immunobiology.

[47]  A. Hayday,et al.  Interleukin 7 (IL-7) selectively promotes mouse and human IL-17–producing γδ cells , 2012, Proceedings of the National Academy of Sciences.

[48]  Sean C. Bendall,et al.  A deep profiler's guide to cytometry. , 2012, Trends in immunology.

[49]  Nikolaos Scarmeas,et al.  The good, bad, and ugly? , 2012, Neurology.

[50]  A. Hayday,et al.  Butyrophilins: an emerging family of immune regulators. , 2012, Trends in immunology.

[51]  J. Casanova,et al.  Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors , 2010, Immunity.

[52]  J. Trowsdale,et al.  BTN1A1, the Mammary Gland Butyrophilin, and BTN2A2 Are Both Inhibitors of T Cell Activation , 2010, The Journal of Immunology.

[53]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Saoudi,et al.  Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. , 2005, Blood.

[55]  David Botstein,et al.  GO: : TermFinder--open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes , 2004, Bioinform..

[56]  A. Annoni,et al.  Expression of Transforming Growth Factor‐β1 in Thymus of Myasthenia Gravis Patients , 2003 .

[57]  A. Annoni,et al.  Expression of transforming growth factor-beta1 in thymus of myasthenia gravis patients: correlation with pathological abnormalities. , 2003, Annals of the New York Academy of Sciences.

[58]  G. Huberfeld,et al.  Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis , 2000, Journal of Neurology.

[59]  G. Nuki,et al.  Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. , 1981, British medical journal.